Sotabase

Career

· Research Assistant, Cornell University2008–
· Postdoctoral Associate in Computer Science, Cornell University2005–2008
· Ph.D. and M.S. in Computer Science and Engineering, University of Washington1998–2005
· Bachelor of Technology in Computer Science and Engineering, Indian Institute of Technology (IIT), Kanpur1994–1998

Publications (18)

An evaluation framework for funding drugs for rare diseases.
Value in Health · 2012
53
cited
Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?
Journal of Clinical Oncology · 2017
49
cited
The effect of pharmacist education on asthma treatment plans for simulated patients
Pharmacy World & Science · 2007
41
cited
Public engagement in priority-setting: results from a pan-Canadian survey of decision-makers in cancer control.
Social Science & Medicine (1967) · 2014
20
cited
Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)
PharmacoEconomics - Open · 2017
17
cited
The impact of cancer drug wastage on economic evaluations
Cancer · 2017
14
cited
The impact of pricing strategy on the costs of oral anti‐cancer drugs
Cancer Medicine · 2019
12
cited
Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?
PharmacoEconomics (Auckland) · 2015
9
cited
Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.
Journal of Clinical Oncology · 2016
9
cited
Understanding the reasons for provincial discordance in cancer drug funding-a survey of policymakers.
Current Oncology · 2018
9
cited
Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?
ESMO Open · 2016
7
cited
Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding.
Current Oncology · 2017
6
cited
Application of Operations Research to Funding Decisions for Treatments with Rare Disease
2013
4
cited
PHP31 A POLICY FRAMEWORK FOR FUNDING DRUGS FOR RARE DISEASES
2009
1
cited
Engaging specialist oncologists in the assessment of oncology drugs in Canada.
The Lancet Oncology · 2017
Impact of intravenous cancer drug wastage on economic evaluations.
2017
Proceedings from a symposium of the Canadian Association of Population Therapeutics--2010 annual conference.
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique · 2011
The impact of pricing strategy on the cost of oral anti-cancer drugs during dose reductions.
2017
Sotabase
Ashish Sabharwal | Researcher Profile | Sotabase | Sotabase